Healthcare innovation only matters if it improves patient outcomes.
From 3 to 5 March, Basel turned into one of the world’s busiest meeting points for healthtech innovation.
The health.tech Global Summit 2026 brought together around 6,000 participants from more than 60 countries, including startups, pharma leaders, investors, clinicians, researchers, and policymakers.
Hosted at Messe Basel, the event featured 250 exhibitors and more than 120 startups, making it one of Europe’s most concentrated gatherings of healthcare innovators this year.
Organised by MCH Group in partnership with Bits & Pretzels, the summit expanded the health.tech conference, previously held in Munich, into a much broader global platform.
The summit leaned heavily toward ecosystem building—conversations, collaborations, and partnerships designed to accelerate healthcare innovation.
The event centred on four core tracks:
- Next-Generation Therapeutic Development, exploring technology-enabled drug discovery and personalised treatments
- Preventive and Personal Health, examining how AI and consumer technologies reshape prevention
- Modernising the Mechanics of Care, focusing on digital innovation in healthcare delivery
- AI in Healthcare, addressing practical clinical applications.
Here are the main themes that emerged at the health.tech Global Summit 2026.
Involve patients first in innovation
One of the clearest themes running through the summit was the need to design healthcare technologies around patients from the very beginning.
Sophie Feary captured the sentiment early in the event:
“MedTech only matters if it matters to patients.”
That idea was echoed by Paola Escamilla Greenham, who reminded innovators that patient involvement should happen early in the development process, not after products are already built.
The message resonated throughout—from early-stage founders to established innovators.
Prof. Dr. Roger Gassert from ETH Zurich’s Rehabilitation Engineering Lab showcased work in robotics and assistive technologies through initiatives like CYBATHLON, where people with disabilities directly test and shape emerging technologies.
Often revealing design challenges that engineers alone might never anticipate.
Thomas Clozel of Owkin asked it simply:
If it isn’t validated by patients, is it worth your time?
AI’s expanding role
AI appeared in nearly every conversation at the summit. A presentation from Thomas Clozel, CEO of Owkin, captured the opportunity and urgency.
Clozel argued that the pharma industry must move beyond traditional, process-driven R&D models and embrace an AI-driven understanding of biology.
Owkin is working toward what it calls Biological Artificial Super Intelligence (BASI). An AI system that works around the clock to generate research hypotheses, test them in automated laboratories, and accelerate the development of new therapies.
Preventive care is now mainstream
Another repeated theme at the summit was the need to shift healthcare systems toward prevention.
Moritz Hartmann from Roche Information Solutions pointed out that many diseases are diagnosed too late. Not because the technology is missing, but because healthcare systems are designed to respond only once symptoms appear.
AI systems are already capable of identifying early disease signals. The challenge now lies in embedding those tools into everyday healthcare workflows.
Making that shift requires system-level change across healthcare delivery.
The challenge of scaling up, moving beyond the pilots
Healthtech innovation staying stuck in the pilot phase was the frustration shared across panels and discussions.
Marianthi Polydorou, a Digital Transformation Leader, highlighted the difficulty of turning a small, successful test into a system that works reliably on a large scale.
Experts across the summit offered several perspectives on how to bridge that gap:
Constantin Landers (NVIDIA) spoke about building unified AI-powered innovation environments that support continuous development.
Max Tschochohei (Google) emphasised evaluating AI systems based on real patient journeys rather than purely technical benchmarks.
Sumu S. (GSK) highlighted the need to design digital endpoints in clinical trials with patient experience in mind.
Betul Susamis Unaran urged organisations to move beyond experimentation and build fully integrated AI strategies.
Healthcare doesn’t suffer from a lack of innovation. It struggles with implementation.
A reminder about the human side of healthcare
Even with all the discussions around AI, innovation, and future technologies, one moment brought the conversation back to a fundamental truth about healthcare.
Infectious disease expert Dr Anthony Fauci said:
“Expect the unexpected.”
In tech, we try to plan for every possible problem, but in healthcare, you realise that the “unexpected problem” is just part of being human.
The power of female leadership
The summit also highlighted the growing influence of women in healthcare leadership.
At the She Leads Healthcare gathering hosted by Farina Schurzfeld and Dr Anne Wichels-Schnieber, speakers focused on mentorship, collaboration, and building stronger networks for female leaders in the industry.
The keynote by Amal Clooney, the internationally renowned human rights lawyer, was a highlight. Her advice to the audience was simple but resonated strongly:
“Don’t be your own worst enemy and try not to be so hard on yourself.”
Innovation on the exhibition floor
Beyond the main stages, the exhibition floor offered a window into emerging technologies across the healthtech ecosystem.
More than 250 exhibitors showcased their technologies, spanning diagnostics, digital therapeutics, AI platforms, medical imaging, and advanced therapeutics.
Few innovations particularly stood out:
InhalPlus, which showcased a device that allows doctors to give medicine to premature babies who are on breathing support without having to disconnect them from the ventilator.
Exploris Health AG, whose Cardio Explorer platform aims to use AI to predict cardiovascular risk before symptoms appear.
Amnova Biotech, whose CEO, Pilar Ferrer, presented the company’s work on an injectable therapy made from birth tissue that could help regenerate the heart after a heart attack.
Other startups participating in the ecosystem included companies such as PulseMedica, Cogniguard, Scanvio Medical, CorTec, Nui Care, AQEMIA, Hexarad, Climedo, DeepLook Medical, Ada Health, and others, reflecting the breadth of innovation on display.
The startup pitch competition
The summit’s startup competition was organised in collaboration with DayOne, Basel’s healthtech innovation platform.
The winner: PulseMedica, a Canadian startup developing advanced imaging and treatment technologies for retinal disease.
Led by CEO Nir Katchinskiy, the company impressed judges with its potential to improve diagnosis and treatment for vision-threatening eye conditions.
The other finalists included:
- Cogniguard, developing vagus nerve stimulation technology aimed at Alzheimer’s disease
- Scanvio Medical, focused on innovations in medical imaging.
Corporate announcements and ecosystem partnerships
Unlike events such as CES or ViVE that often centre around major product launches, the health.tech Global Summit leaned more heavily toward ecosystem building.
However, it still featured several notable announcements.
One came from Tom Hale, CEO of Oura. Oura launched its own large language model specifically designed for women’s health insights.
Rather than relying on generic AI systems, Oura’s LLM combines clinical research, expert knowledge, and its extensive wearable data ecosystem to build a specialised health AI platform.
The summit itself also reflected strong industry partnerships.
Roche joined as a main event partner, underscoring Basel’s role as one of the world’s most important life sciences hubs.
Basel unlocked: Taking the summit beyond the conference halls
One of the event’s distinctive features was Basel Unlocked, a programme designed to connect participants directly with the city’s life sciences ecosystem.
Instead of staying inside conference rooms, attendees were invited to visit innovation hubs and global companies across Basel, including major pharmaceutical players.
The idea, as Managing Director Andreas Nef explained, was to go beyond traditional conference formats.
“We go far beyond the traditional conference experience and give you exclusive access behind the scenes of the world’s leading pharmaceutical and health tech headquarters. It’s where global innovation is not just discussed, but actively shaped.”
Shaping the future of healthcare
As the summit drew to a close, organisers Andreas Nef and Caoimhe Vallely-Gilroy reflected on the event’s broader ambition:
“You are not just attending a summit, you are shaping a system.”
When you leave the conference halls behind, when you step into real innovative spaces, and when you balance deep industry insight with genuine human connection, you do more than attend a conference. You collectively begin to shape the system itself.
And if the discussions at the health.tech Global Summit 2026 are any indication, the future of healthcare will be defined by three forces:
AI, prevention, and the ability to turn innovation into real clinical care.
Stay ahead of where healthcare innovation is unfolding next. Global conferences, startup showcases, and industry-defining events.
Sign up for the All Health Tech event calendar. We track the conversations that matter, so you don’t miss what’s shaping healthtech next.
